The Brief Case: Invasive Ceftriaxone-Resistant Nontyphoidal Salmonella and Antimicrobial Susceptibility Testing Considerations.
作者信息
Tao Lili, Foster Pamela, Russo Carmella, Cassat James E, Humphries Romney M
机构信息
Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Department of Pediatrics, Division of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
出版信息
J Clin Microbiol. 2023 May 23;61(5):e0075022. doi: 10.1128/jcm.00750-22.
Abstract
摘要
相似文献
1
The Brief Case: Invasive Ceftriaxone-Resistant Nontyphoidal Salmonella and Antimicrobial Susceptibility Testing Considerations.
J Clin Microbiol. 2023 May 23;61(5):e0075022. doi: 10.1128/jcm.00750-22.
2
Clinical outcomes of nalidixic acid, ceftriaxone, and multidrug-resistant nontyphoidal salmonella infections compared with pansusceptible infections in FoodNet sites, 2006-2008.
Foodborne Pathog Dis. 2014 May;11(5):335-41. doi: 10.1089/fpd.2013.1642. Epub 2014 Mar 11.
3
Estimated Incidence of Antimicrobial Drug-Resistant Nontyphoidal Salmonella Infections, United States, 2004-2012.
Emerg Infect Dis. 2016 Jan;23(1):29-37. doi: 10.3201/eid2301.160771.
4
Ceftriaxone-Resistant Nontyphoidal Salmonella from Humans, Retail Meats, and Food Animals in the United States, 1996-2013.
Foodborne Pathog Dis. 2017 Feb;14(2):74-83. doi: 10.1089/fpd.2016.2180. Epub 2016 Nov 18.
5
Nontyphoidal Salmonella enterica Nonsusceptible to Both Levofloxacin and Ceftriaxone in Nebraska, United States 2014-2015.
Foodborne Pathog Dis. 2018 Apr;15(4):235-238. doi: 10.1089/fpd.2017.2361. Epub 2018 Jan 3.
6
Epidemiology and Genomics of Invasive Nontyphoidal Salmonella Infections in Kenya.
Clin Infect Dis. 2015 Nov 1;61 Suppl 4(Suppl 4):S317-24. doi: 10.1093/cid/civ711.
7
Susceptibility of Typhoidal, Nontyphoidal, and Extended-Spectrum-β-Lactamase-Producing to Ceftolozane/Tazobactam.
Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0122421. doi: 10.1128/AAC.01224-21. Epub 2021 Oct 18.
8
Emergence of multidrug-resistant Salmonella spp. and isolates with reduced susceptibility to ciprofloxacin in Kuwait and the United Arab Emirates.
Diagn Microbiol Infect Dis. 2008 Jan;60(1):71-7. doi: 10.1016/j.diagmicrobio.2007.07.007. Epub 2007 Oct 10.
9
Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
Diagn Microbiol Infect Dis. 2006 Jan;54(1):13-21. doi: 10.1016/j.diagmicrobio.2005.06.013. Epub 2005 Nov 14.
10
Proposed Epidemiological Cutoff Values for Ceftriaxone, Cefepime, and Colistin in Salmonella.
Foodborne Pathog Dis. 2018 Nov;15(11):701-704. doi: 10.1089/fpd.2018.2490. Epub 2018 Aug 28.
引用本文的文献
1
: A Review of Antibiogram Journey in Developing Countries.
Infect Disord Drug Targets. 2024;24(6):e230124225976. doi: 10.2174/0118715265255339240102110929.
本文引用的文献
1
Azithromycin susceptibility testing for Salmonella enterica isolates: discordances in results using MIC gradient strips.
J Antimicrob Chemother. 2020 Jul 1;75(7):1820-1823. doi: 10.1093/jac/dkaa097.
2
The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017.
Lancet Infect Dis. 2019 Dec;19(12):1312-1324. doi: 10.1016/S1473-3099(19)30418-9. Epub 2019 Sep 24.
3
Extended-spectrum β-Lactamase Acquisition in Patients Receiving Systemic Cephalosporin Treatment for Salmonella spp. and Shigella spp. Infection.
Clin Infect Dis. 2020 Feb 3;70(4):714-716. doi: 10.1093/cid/ciz468.
4
Relapse of typhoid fever following delayed response to meropenem: A case report and review of previously published cases indicating limited clinical efficacy of meropenem for the treatment of typhoid fever.
Ger Med Sci. 2019 Jan 7;17:Doc01. doi: 10.3205/000267. eCollection 2019.
5
Evaluation of Surrogate Disk Tests for Detection of Ciprofloxacin and Levofloxacin Resistance in Clinical Isolates of Salmonella enterica.
J Clin Microbiol. 2015 Nov;53(11):3405-10. doi: 10.1128/JCM.01393-15. Epub 2015 Aug 19.
6
Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.
Clin Microbiol Rev. 2015 Oct;28(4):901-37. doi: 10.1128/CMR.00002-15.
7
Carbapenemase-producing Salmonella enterica isolates in the UK.
J Antimicrob Chemother. 2015 Jul;70(7):2165-7. doi: 10.1093/jac/dkv075. Epub 2015 Mar 19.
8
Performance of Etest and disk diffusion for detection of ciprofloxacin and levofloxacin resistance in Salmonella enterica.
J Clin Microbiol. 2015 Jan;53(1):298-301. doi: 10.1128/JCM.02715-14. Epub 2014 Oct 29.
9
In vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent changes to CLSI standards.
Clin Infect Dis. 2012 Oct;55(8):1107-13. doi: 10.1093/cid/cis600. Epub 2012 Jul 2.
10
Recurrent infections caused by cefotaxime- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis treated successfully with imipenem.
J Infect. 2005 Oct;51(3):e163-5. doi: 10.1016/j.jinf.2004.12.011. Epub 2005 Jan 28.
Zotero 插件